The effect of intranasal oxytocin treatment on conditioned fear extinction and recall in a healthy human sample - Wikidata - thesis-toulmin - TriplyDB

The effect of intranasal oxytocin treatment on conditioned fear extinction and recall in a healthy human sample

The effect of intranasal oxytocin treatment on conditioned fear extinction and recall in a healthy human sample

http://www.wikidata.org/entity/Q33761390

about

Modulation of Fear Extinction by Stress, Stress Hormones and Estradiol: A Review.From Pavlov to PTSD: the extinction of conditioned fear in rodents, humans, and anxiety disorders.Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders Conditioned fear and extinction learning performance and its association with psychiatric symptoms in active duty Marines.Mechanisms to medicines: elucidating neural and molecular substrates of fear extinction to identify novel treatments for anxiety disorders Effects of oxytocin on background anxiety in rats with high or low baseline startle Gradual extinction reduces reinstatement Conditioned fear associated phenotypes as robust, translational indices of trauma-, stressor-, and anxiety-related behaviors Intranasal Oxytocin Affects Amygdala Functional Connectivity after Trauma Script-Driven Imagery in Distressed Recently Trauma-Exposed Individuals.Preventing PTSD with oxytocin: effects of oxytocin administration on fear neurocircuitry and PTSD symptom development in recently trauma-exposed individuals.Oxytocin differentially modulates pavlovian cue and context fear acquisition.Attachment Style Moderates the Effects of Oxytocin on Social Behaviors and Cognitions During Social Rejection: Applying an RDoC Framework to Social Anxiety.Long-term exposure to intranasal oxytocin in a mouse autism model.Looking beyond Fear and Extinction Learning: Considering Novel Treatment Targets for Anxiety.Oxytocin affects the connectivity of the precuneus and the amygdala: a randomized, double-blinded, placebo-controlled neuroimaging trial.Intranasal oxytocin reduces provoked symptoms in female patients with posttraumatic stress disorder despite exerting sympathomimetic and positive chronotropic effects in a randomized controlled trial Effects of intranasal oxytocin on amygdala reactivity to emotional faces in recently trauma-exposed individuals.Intranasal Oxytocin Administration Dampens Amygdala Reactivity towards Emotional Faces in Male and Female PTSD Patients.Reward learning as a potential target for pharmacological augmentation of cognitive remediation for schizophrenia: a roadmap for preclinical development.Corticotropin-releasing factor peptide antagonists: design, characterization and potential clinical relevance Prospects for the pharmacological prevention of post-traumatic stress in vulnerable individuals.Investigational drugs under development for the treatment of PTSD.Oxytocin and Anxiety Disorders: Translational and Therapeutic Aspects.A Precision Medicine Approach to Oxytocin Trials.New dimensions in the use of rodent behavioral tests for novel drug discovery and development.On the Road to Translation for PTSD Treatment: Theoretical and Practical Considerations of the Use of Human Models of Conditioned Fear for Drug Development.The role of oxytocin in relationships between dogs and humans and potential applications for the treatment of separation anxiety in dogs.Salivary Oxytocin and Vasopressin Levels in Police Officers With and Without Post-Traumatic Stress Disorder.Integrating NIMH Research Domain Criteria (RDoC) into PTSD Research.HIGH AND LOW THRESHOLD FOR STARTLE REACTIVITY ASSOCIATED WITH PTSD SYMPTOMS BUT NOT PTSD RISK: EVIDENCE FROM A PROSPECTIVE STUDY OF ACTIVE DUTY MARINES.Fear learning alterations after traumatic brain injury and their role in development of posttraumatic stress symptoms.Intranasal oxytocin administration prior to exposure therapy for arachnophobia impedes treatment response.Oxytocin receptor neurotransmission in the dorsolateral bed nucleus of the stria terminalis facilitates the acquisition of cued fear in the fear-potentiated startle paradigm in rats.Oxytocin and Anxiety Disorders.Augmenting Prolonged Exposure therapy for PTSD with intranasal oxytocin: A randomized, placebo-controlled pilot trial.Ameliorating Impact of Prophylactic Intranasal Oxytocin on Signs of Fear in a Rat Model of Traumatic Stress.Effects of oxytocin on working memory and executive control system connectivity in posttraumatic stress disorder

P2860

Q26767636-371873B2-264C-4DCA-9906-1C880C17991E Q26851172-D89BC094-8948-4E8C-A8C2-BCF8DEAAEE96 Q27006437-FEDD065E-9B77-40EA-BB8E-1C618A378E2D Q27304448-308ADE02-0296-45A1-95AB-F0D0CD3C707F Q28396555-2E40DE24-A109-4982-818F-AE35A7BA3A63 Q30355402-9C534518-B03B-4854-ABE8-D6B46EDB5005 Q30401504-A3A2911C-03B1-40D6-B1FF-0712F6730628 Q30433318-9DDA9B47-CA17-46E3-A9CA-BEB66EC678AC Q30727730-05035BDC-EB40-46B5-8DA8-8C3BDC918596 Q33589504-CA57F234-99B6-47E1-B95E-75D89555F16D Q33802793-AAADB594-5E5D-40CF-88C7-FD91FAFD92BC Q34549329-7D1F53D8-9CB9-417A-866E-E1D31F49CC73 Q34657990-ED053297-BB9E-4294-B59B-6EB97706E9BC Q35098882-CB4D9ECE-3E0D-4A41-88BF-D86B874DD75F Q35224273-FD5537AB-65B1-4BF5-AE5F-BDE6FE60A6A6 Q36283417-0C84721A-2D3B-44C1-B462-162F57C17643 Q36521837-93F32596-5214-4D0D-9EBD-6EB296AFAE70 Q36798984-D2DC7F44-FF53-4CA9-BA91-07DF889A1CBB Q36935148-CFE6C586-6373-415A-8A13-F9D444F76C28 Q37662647-85C08233-22EB-472A-A445-35940CDED0C9 Q38185606-CBE41F8D-8E1D-48F9-83B7-A5B53421E7CA Q38378939-36676A6D-763A-4914-9A87-E8C482C5DA10 Q38624604-98DBC686-D9CC-4169-98EF-B396DFE7B675 Q38641885-E9149706-6247-4A81-A7C7-039ACB1D2537 Q38740954-03C86000-A8BF-4C77-AC98-2F6ED4BD6AE4 Q38852116-1F810428-0EEF-48A3-AF1B-01AE17377A1D Q38944881-5EEDFBAD-C319-4B65-A13F-E59919584E4A Q38983770-C58A6650-E05C-493A-8680-51BE2667E891 Q39200073-0A531452-D413-4593-BA7E-4D0B1ACC173D Q39996074-18371BCE-64C2-4A8F-98DE-0FBDAB5BAF3F Q46143306-A62AC7C2-9318-40C0-9182-D4E1E682E07C Q46521486-BC100745-A48E-4B0E-A518-BFFF0F83DD35 Q47324152-7AEF4D75-9A28-41C5-9C18-2B3C83ED9518 Q47645718-AD0F04F5-3C0A-4375-81C9-131425C81E79 Q47665395-276E11CA-82F5-4CB9-97F8-492456AB057C Q54970468-681BBF2E-933F-4F97-8477-081E4474734D Q57172126-FF1FCF50-3B1F-4906-8FF8-D60D245144F3

P2860

The effect of intranasal oxytocin treatment on conditioned fear extinction and recall in a healthy human sample

http://www.wikidata.org/entity/Q33761390

description

2013 nî lūn-bûn

@nan

2013 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

The effect of intranasal oxyto ...... call in a healthy human sample

@ast

The effect of intranasal oxyto ...... call in a healthy human sample

@en

type

label

The effect of intranasal oxyto ...... call in a healthy human sample

@ast

The effect of intranasal oxyto ...... call in a healthy human sample

@en

prefLabel

The effect of intranasal oxyto ...... call in a healthy human sample

@ast

The effect of intranasal oxyto ...... call in a healthy human sample

@en

P1433

Q33761390-B306066E-A905-45BC-B1B2-AE66602CBB98

P1476

Q33761390-51E7E5AC-E398-4576-9A3C-61D2A72DE584

P2093

Q33761390-2788DE82-4D21-4FB8-BD2C-A4FE8FF67A11

Q33761390-4F980ECC-B757-4306-941C-12AD14B2C979

Q33761390-52D8E378-53B9-4CC7-A44B-EF1516718DBF

Q33761390-B1F9B2C6-9783-4889-BEEB-3C4E583E6815

Q33761390-D783BA18-0AA9-4176-AC40-987A4AFD2632

Q33761390-D8561379-AE32-4CBD-B351-A23028CE7029

P2860

Q33761390-01B09274-6F1F-4B86-B692-E5A6445E0A20

Q33761390-02076563-FDF4-4010-A976-FE8F122E69B4

Q33761390-123282D9-4B88-4255-A450-B8C1FDF7BE57

Q33761390-1364036E-9A69-4C39-BC21-182F093B47CE

Q33761390-192FBAE1-A5ED-4D84-992C-BEB08ADF446B

Q33761390-1BE29C5A-9A96-43DA-B4CD-6EDEDF1234D1

Q33761390-1E6CF3A8-2B53-4AC0-A137-C6DA0693C9B9

Q33761390-1EE7D0C3-2222-41DE-84B7-75607FB8ACC6

Q33761390-226D5F2F-AD3E-4811-BBDA-C776E265240A

Q33761390-297EA573-F914-4022-A2E7-C185E2417746

P2888

Q33761390-A6D75D72-96E4-4EC0-8C66-1804433C6C77

P304

Q33761390-D876388C-382F-4C41-9FEC-BA5970907170

P31

Q33761390-DFA3A3EA-37C4-4129-AE85-7EEE3E908A3D

P356

Q33761390-57017EF7-DDDD-4C07-A947-543A4EC6EA65

P433

Q33761390-A881DCE0-846A-42E5-9D36-6A6CCDA0D1D8

P478

Q33761390-D7951653-52B4-48B2-8D40-1B88561648AD

P577

Q33761390-7A74377E-3F80-466F-B15B-E6038CC93D85

P6179

Q33761390-07AB1BBC-D202-4454-9F5D-6B8928779415

P698

Q33761390-3224D9A6-1352-40F9-97FF-EDF1450C427C

P921

Q33761390-DD5FD034-8EC4-4066-97B9-C74A2A0CB18F

P932

Q33761390-7B59D5D0-C0C3-41DB-B479-EF9918C69925

P356

S00213-013-3099-4

P1433

Psychopharmacology

P1476

The effect of intranasal oxyto ...... call in a healthy human sample

@en

P2093

David Feifel

http://www.w3.org/2001/XMLSchema#string

Dean Acheson

http://www.w3.org/2001/XMLSchema#string

James Lohr

http://www.w3.org/2001/XMLSchema#string

Rebecca McKinney

http://www.w3.org/2001/XMLSchema#string

Sofieke de Wilde

http://www.w3.org/2001/XMLSchema#string

Victoria Risbrough

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)

Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication

Oxytocin Attenuates Affective Evaluations of Conditioned Faces and Amygdala Activity

Oxytocin Modulates Neural Circuitry for Social Cognition and Fear in Humans

Vasopressin and Oxytocin Excite Distinct Neuronal Populations in the Central Amygdala

Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia.

Oxytocin increases anxiety to unpredictable threat.

Neurobiological basis of failure to recall extinction memory in posttraumatic stress disorder

Fear extinction as a model for translational neuroscience: ten years of progress.

Amygdala, medial prefrontal cortex, and hippocampal function in PTSD

P2888

s00213-013-3099-4

P304

199-208

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00213-013-3099-4

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

229

http://www.w3.org/2001/XMLSchema#string

P577

2013-05-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1037226224

http://www.w3.org/2001/XMLSchema#string

P698

23644911

http://www.w3.org/2001/XMLSchema#string

P921

P932

5458114

http://www.w3.org/2001/XMLSchema#string